iPCSK9

Department of Atherosclerosis of SOCERGS
Indications of the use of PCSK9 Inhibitors in patients with High Risk and Very High Cardiovascular risk.

Authors:

Paulo Eduardo Ballvé Behr
São Lucas Hospital of PUCRS

Emilio Hideyuki Moriguchi
Faculty of Medicine, Federal University of Rio Grande do Sul; Department of Cardiology, Hospital of Clinics of Porto Alegre, Porto Alegre, Brazil.

Iran Castro
Institute of Cardiology
University Foundation of Cardiology

Luiz Carlos Bodanese
São Lucas Hospital of PUCRS

Oscar Pereira Dutra
Institute of Cardiology
 University Foundation of Cardiology

Paulo Ernesto Leães
Santa Casa de Misericórdia Brotherhood of Porto Alegre

Pedro Pimentel Filho
Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brazil